BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SFL's Managing Director Invited to Speak at Max Planck Innovation GmbH Biotech NetWorkshop Event in Munich, Germany


3/5/2013 10:58:38 AM

05-March-2013 –SFL is pleased to announce that Shayesteh Fürst-Ladani, SFL’s Managing Director, has been invited to give a presentation at the prestigious Innovation Biotech NetWorkshop Event, to be held in Munich, Germany, from 6-8 March 2013 and jointly hosted by Max Planck Innovation and Ascenion. Max Planck Innovation is responsible for technology transfer from the research institutes of the Max Planck Society, a leading organization in research. Ascenion is a subsidiary of the Life Science Foundation for the Promotion of Science and Research.

During the afternoon session on Wednesday 7 March, Shayesteh will be giving a presentation on the role of regulatory affairs in product development and in communication with healthcare authorities. In her talk, she will outline the key role that regulatory affairs plays in innovation and the approach companies require for a successful regulatory strategy.

“I aim to shed light on some of the key developments in the field of regulatory affairs that affect companies in the life sciences sector,” commented Shayesteh. “Entrepreneurial companies must adopt a solid regulatory strategy if they wish to succeed in bringing innovative products to the market and satisfy unmet medical needs.”

Shayesteh is the Managing Director and founder of SFL. She has comprehensive experience in formulating global regulatory strategies and provides support for the development of drugs, orphan drugs, drug and device combination products, borderline products, medical devices, in vitro diagnostics and advanced therapy medicinal products.

Shayesteh is Chair of the Combination Products Topic Group at EuropaBio. She has been member of the Program Committee of DIA EuroMeeting for 2011, 2012 and 2013 leading the Theme Drugs, Devices, In Vitro Diagnostics and their Combinations. In 2012 she received the Open University Business School’s Alumni Award Outstanding Contribution to an Organization.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES